Abbreviations and Terminology: ACTH, adrenocorticotropic hormone; AMG, aminoglutethimide; CE, cholesteryl ester; FSH, follicle-stimulating hormone; 25-OHC, 25-hydroxycholesterol; 3β-HSD, 3β-hydroxysteroid dehydrogenase; LDLR, LDL receptor; LRH-1, liver receptor homolog-1; P450scc, P450 cholesterol side chain-cleavage enzyme; SR-BI, scavenger receptor class B member I; SREBP, sterol regulatory element-binding protein; SCAP, SREBP cleavage-activating protein; StAR, steroidogenic acute regulatory protein; TGFβ1, transforming growth factor β1. In all, this study reveals that ovarian granulosa cells retain the cholesterol homeostatic control machinery like non-steroidogenic cells, while during active steroidogenesis utilize SR-BI to evade such feedback control.
INTRODUCTION
Cholesterol is an essential structural component of mammalian cell membrane, and precursor for the synthesis of steroid hormones and bile acids (1) . During ovarian steroid hormone synthesis, cholesterol is first transported into mitochondrial inner membrane facilitated by the steroidogenic acute regulatory protein (StAR), and then converted to an important sex steroid progesterone under sequential actions of the mitochondrial enzyme P450 cholesterol side chain-cleavage enzyme (P450scc) and endoplasmic reticulum enzyme 3β-hydroxysteroid dehydrogenase (3β-HSD). Progesterone could be further enzymatically processed into androgens and estrogens (2) . Cellular cholesterol could be derived from the de novo synthesis pathway or from circulating lipoproteins. For steroidogenic cells, lipoproteins are the major source that provide sufficient cholesterol to meet the demand of steroid hormone synthesis (3) . Aside from the ubiquitous LDL receptor (LDLR)-mediated endocytic uptake of LDL-cholesterol adapted by most cell types, steroidogenic cells additionally utilize HDL-derived cholesterol through scavenger receptor class B member I (SR-BI), which selectively uptakes cholesteryl ester (CE) without internalizing the whole lipoprotein particle (4, 5) . Lipoprotein utilization in steroidogenic cells could be different among species. For rodents HDL is the major circulating lipoprotein and SR-BI serves as the principal lipoprotein receptor in steroidogenic tissues (4, (6) (7) (8) , whereas for human LDL is the major cholesterol-carrying lipoprotein and the role of LDLR and SR-BI is not entirely clear (9) . Earlier limited studies suggest that LDL and LDLR participate in human steroidogenesis as adrenocorticotropic hormone (ACTH)-increased cortisol level was lower in LDLR-deficient homozygous familial hypercholesterolemia patients and LDL-deficient hypobetalipoproteinemia patients compared with normal subjects (10, 11) . Additionally, a most recent study implicates SR-BI also takes part in human adrenal steroidogenesis as human subjects with a missense mutation of SR-BI had reduced corticotropin-stimulated adrenal corticosteroid level, and cells with such mutation had defective uptake of HDL-CE by guest, on November 9, 2017 www.jlr.org Downloaded from (12) .
In steroidogenic cells, SR-BI and LDLR are regulated by tropic hormones.
Gonadotropins and ACTH increased the expression of SR-BI and LDLR in murine granulosa cells and adrenocortical cells, respectively (8, 13, 14) . Treatment with an ovulation-inducing stimulus of follicle-stimulating hormone (FSH) followed by human chorionic gonadotropin (hCG) also increased the expression of LDLR and SR-BI in rhesus macaque granulosa cells (15) . Also, luteinized granulosa cells retrieved from women receiving gonadotropin-based ovulatory regimen had increased cholesterol uptake from LDL and HDL to support steroidogenesis (16) . Previous studies revealed that in non-steroidogenic cells, cellular cholesterol level is under surveillance by the homeostatic control mechanism with LDLR being a key regulatory target (17) . When cells are at a state of sterol insufficiency, the endoplasmic reticulum-bound transcription factors, sterol regulatory element-binding proteins (SREBPs) are first transported to the Golgi apparatus through the assistance of a sterol-sensing molecule, SREBP cleavage-activating protein (SCAP). Then under the action of Golgi proteases, the N-terminal transcription factor domain of SREBP is released and translocates into the nucleus, and thereby activates transcription of target genes. There are two SREBP genes encoding three proteins, the splice variants SREBP-1a and SREBP-1c, and SREBP-2. SREBP-2 preferentially controls cholesterogenic genes including LDLR (Ldlr) and HMG-CoA reductase (Hmgcr), while SREBP-1c controls lipogenic genes and SREBP-1a activates both categories. Also, it has been reported that SR-BI is potentially regulated by SREBP-1a transactivation through sterol response element (SRE)-like sites in its promoter (18) . Notably, SR-BI is a known target of liver receptor homolog-1 (LRH-1), a nuclear receptor of the NR5A subfamily that is critically involved in the regulation of cholesterol metabolism including reverse cholesterol transport, bile acid synthesis, and ovarian steroidogenesis (19) . Whether and how SREBP-mediated cholesterol feedback control mechanism and LRH-1 are involved in by guest, on November 9, 2017 www.jlr.org Downloaded from the regulation of LDLR and SR-BI in steroidogenic cells is not clear (20) .
Pituitary-secreted FSH is the master hormone that promotes ovarian follicle development and granulosa cell differentiation before ovulation (21) , and ovarian cytokine transforming growth factor (TGFβ1) plays an important role to facilitate FSH action (22, 23) including enhancement of progesterone production through increased expression of steroidogenic proteins StAR, P450scc, and 3β-HSD (24) (25) (26) (27) . We were intrigued by how cellular cholesterol is controlled in steroidogenic cells when facing a great demand of cholesterol for active steroidogenic activity. This study therefore was initiated to explore how cholesterol entry mediators LDLR and SR-BI are regulated in response to FSH and TGFβ1 stimulation of steroidogenesis in ovarian granulosa cells. Primary culture of granulosa cells from gonadotropin-primed immature rats was used as both SR-BI and LDLR pathways are active in in vitro culture condition (8, 13) . There were two specific aims. The first was to investigate FSH and TGFβ1 regulation of the expression of SR-BI and LDLR, and their subcellular localization as well as functional involvement in steroidogenesis. The second aim was to examine sterol responsiveness of the two receptors, and the potential involvement of two key transcription factors SREBP-2 and LRH-1. 
MATERIALS AND METHODS

Materials
Cell culture and treatment
Isolation of ovarian granulosa cells from gonadotropin-primed immature rats was performed as previously described (25) . In brief, immature rats were injected once subcutaneously with 15 IU of eCG to stimulate the development of multiple follicles to antral follicle stage. Forty-eight hours later, ovarian granulosa cells of mid-to large-sized antral follicles were isolated and seeded into EHS matrigel-coated culture wares in growth medium (DMEM/F-12, 1:1, 2 g/ml bovine insulin, 0.1% fatty acid-free BSA, 100 U/ml penicillin and 100 g/ml streptomycin), and were allowed to attach for 20 h at 37C, 5% CO 2 -95% air.
Cultured cells were then incubated in incubation medium (DMEM/F12, 1:1, 0.1% lactalbumin hydrolysate, 100 U/ml penicillin and 100 g/ml streptomycin) for an additional 20 h before the beginning of treatment. Cultured granulosa cells at this point and through additional 48 h of cultivation period exhibited a flattened and fibroblastic morphology, while treatment with FSH rapidly stimulated cell rounding that faded after 24 h; on the other hand, combined treatment with FSH and TGF1 induced cell rounding phenomenon that lasted to 48 h, and cells were able to revert to fibroblastic shape 24 h after changing to fresh culture medium (28).
Biochemical data also showed that TGF1 potentiated FSH action to stimulate granulosa cell progesterone production, a differentiation maker that remained low in the control group during 48-h culture period (25) (26) (27) (28) (29) . Together, these observations indicate that this cell model does not undergo spontaneous luteinization and is ideal for studying regulation of granulosa cell differentiation.
Immunoblotting analysis
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Granulosa cells (approximately 6 x 10 6 ) were cultured in matrigel-coated 60-mm culture dishes, and treated as described in the legends. At the end of culture, cells were extracted with lysis buffer (50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 1 mM EDTA-disodium, 1% NP-40 Alternative, 0.25% sodium-deoxycholate, 1 mM phenylmethylsulfonyl fluoride, 1 μg/ml each of aprotinin, leupeptin and pepstatin, 5 mM sodium orthovanadate, and 5 mM sodium fluoride), and sonicated using an ultrasonicator (Missonix Inc., Farmingdale, NY, USA). Cell lysates were analyzed for SR-BI, LDLR, SREBP-2, and LRH-1 with β-actin used as an internal control. SDS-PAGE analysis was performed with equal protein amount for each sample. After electrophoresis and electroblotting, blots were blocked with 5% fat-free milk and then incubated with primary antibodies. Specific signals were visualized using HRP-conjugated secondary antibodies and enhanced chemiluminescence substrate (PerkinElmer Inc., Waltham, MA, USA). Signals on x-ray films were quantified using a two-dimensional laser scanning densitometer (Molecular Dynamics, Sunnyvale, CA, USA).
Immunofluorescence analysis
Granulosa cells (approximately 5 x 10 5 ) were seeded on matrigel-coated 12-mm cover slips, and treated as described in the legends. At the end of culture, cells were fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.05% Triton X-100 for 5 min, and then incubated in the blocking reagent (3% BSA and 3% goat serum in PBS) for 1 h. Cells were then incubated with rabbit antibodies against SR-BI or LDLR, or isotypic immunoglobulin serving as a negative control for 1 h, followed by fluorescein isothiocyanate-conjugated goat anti-rabbit IgG for 1 h. The cover slips were mounted on glass slides, and viewed under a fluorescence microscope (Olympus BX50, Tokyo, Japan) equipped with a mercury arc lamp and photographed using SPOT image capture system (Diagnostic Instruments Inc., Sterling Heights, MI, USA). Only the fluorescence emission intensity, exposure time, and signal output gain value could affect the outcome signal intensity. In order not to have overexposed images, the system was set to automatically capture image of a sample that displayed the most intense fluorescence signal, that is, FSH+TGF1-treated cells. Then the exposure time and signal output gain value of this image was used to capture all of the subsequent samples in a single experiment. By this way the fluorescent images could reflect the actual emission signal for comparison among samples.
Steroidogenic response to lipoprotein supplementation
Human HDL 3 (hHDL 3 ) and human LDL (hLDL) were prepared as previously described (30). In brief, blood samples from healthy donors were centrifuged at 2000 g for 30 min to obtain sera, which were then supplemented with 3 mM EDTA-disodium and 1 mM phenylmethylsulfonyl fluoride to avoid proteolytic degradation. Lipoproteins were isolated from the sera through sequential floatation ultracentrifugation using KBr solution ) were cultured in matrigel-coated 24-well plates, treated with FSH (10 ng/ml) and/or TGFβ1 (0.5 ng/ml) for 24 h, and then given hHDL 3 or hLDL for an additional 3 h. At the end of culture, progesterone content in the conditioned medium was determined by enzyme immunoassay described below. To understand the potential role of SR-BI in the process, a selective inhibitor BLT-1 was given 1 h prior to lipoprotein administration. The experimental designs were shown in Figures 2A and 3A . Also, we have determined the by guest, on November 9, 2017 www.jlr.org Downloaded from progesterone content in lipoprotein preparations, and the estimated progesterone content in our highest treatment dose of hHDL 3 and hLDL was approximately 20~40% of that detected in the conditioned media of unstimulated control cells, and less than 1% in FSH+TGF1-treated group. The progesterone production of granulosa cells was calculated by subtracting the progesterone content in supplemented lipoprotein from that in the conditioned medium sample, and then normalized to the cell number determined by crystal violet assay as previously described (33).
Enzyme immunoassay
Progesterone levels in the conditioned media were measured using enzyme immunoassay as previously described (26, 27) . Progesterone antisera and progesterone-conjugated horseradish peroxidase were produced and verified in the laboratory of Dr. Leang-Shin Wu (National Taiwan University, Taipei, Taiwan). In brief, progesterone standards or conditioned medium samples were incubated in the presence of progesterone-conjugated horseradish peroxidase in anti-progesterone antibody-coated 96-well plates for 2 h at room temperature. This was then rinsed off, and peroxidase substrate 2,20-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) diammonium (Sigma Chemical Co.) was added and incubated for 2 h. The absorbance of reaction products was measured at 410 nm using a multimode microplate reader (Infinite 200 PRO, Männerdorf, Switzerland).
Fluorescent staining of cellular neutral lipids
Granulosa cells (approximately 5 x 10 5 ) grown on cover slips were treated with FSH and/or TGFβ1 for 24 h followed by the addition of hHDL 3 (500 g/ml) or hLDL (100 g/ml) in the absence or presence of aminoglutethimide (0.5 mM; an inhibitor of P450scc) for an additional 24 h. At the end of culture, cells were fixed with 4 % paraformaldehyde for 15 min, and then stained with 2 g/ml BODIPY 493/503 (Molecular Probes, Life Technologies Inc., Carlsbad, CA, USA) for 10 min. Cells on cover slips were then mounted on glass slides, and photographed as described above in Immunofluorescence.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis
Granulosa cells (approximately 2 x 10 6 ) were cultured in matrigel-coated 35-mm culture dishes, and treated as described in the legends. At the end of culture, cells were extracted with 1 ml of Trizol reagent per 35-mm dish. After adding 200 l of chloroform, the mixture was centrifuged at 12000 g for 15 min for phase separation. The upper aqueous phase was retained, mixed with isopropanol at 1:1 ratio and allowed to stand at room temperature for 30 min, and then centrifuged at 12000 g for 10 min to precipitate RNA. The pellet was washed with 75% ethanol, and then dissolved in ddH 2 O containing 0.1% DEPC.
RNA concentration of each sample was estimated using ND-1000 spectrophotometer (Thermo Scientific Inc., Wilmington, DE, USA). RNA sample was then reverse-transcribed to cDNA using MMLV reverse-transcriptase according to the manufacturer's protocol. Taq DNA polymerase was used to amplify cDNA for Scarb1, Ldlr and Hmgcr with Actb used as an internal control. The forward and reverse primer pairs used are listed in Table 1 . The PCR cycle number used for each gene was within the linear range of amplification. PCR was performed using Aztec PC-816 thermal Cycler (Astec Co., Fukuoka, Japan), and the products were analyzed by 1.5% agarose gel electrophoresis with gel containing HealthView nucleic acid stain (Genomics Co., Taipei, Taiwan), and visualized with a UV transilluminator (Quantum ST-1000, Eberhardzell, Germany).
Chromatin immunoprecipitation (ChIP) analysis
ChIP analysis was performed as previously described (28) mM sodium orthovanadate, and 5 mM sodium fluoride). This was then sonicated using an ultrasonicator to obtain DNA fragments with sizes at a range of approximately 400 to 1000 bp. The samples were then frozen, thawed on ice, and centrifuged at 15000 g for 15 min at 4C to precipitate SDS. The supernatant was diluted five folds with dilution buffer (16.7 mM Tris-HCl, pH 8.0 containing 167 mM NaCl, 1.2 mM EDTA-disodium, 1.1% Triton X100, 0.01% SDS, and the cocktail of protease and phosphatase inhibitors), and precleared by incubating with 50 l of protein G agarose blocked with 0.1% BSA and 50 g/ml salmon sperm DNA for 2 h at 4C. This was centrifuged, and the supernatant was incubated with antibodies overnight at 4C, followed by another 50 l of blocked protein G agarose for 6 h.
To remove non-specific binding, the sample was washed sequentially with low-salt wash buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA-disodium, 1% Triton X-100, 0.1% SDS), high-salt wash buffer (20 mM Tris-HCl pH 7.4, 500 mM NaCl, 2 mM EDTA-disodium, 1% Triton X-100, 0.1% SDS), LiCl buffer (10 mM Tris-HCl, pH 8.0, 250 mM LiCl, 1 mM EDTA-disodium, 1% NP-40, 1% sodium deoxycholate), and TE buffer (10 mM Tris-HCl, 1mM EDTA-disodium, pH 8). The sample was then eluted with 400 l of elution buffer (0.1 M NaHCO 3 , 1% SDS). The eluate was then incubated at 65C in the presence of 0.2 M NaCl for 4 h to reverse crosslinks, and then with 100 g/ml proteinase K at 50C for 1 h to remove associated proteins. After phenol/chloroform extraction and ethanol precipitation, DNA sample was dissolved in TE buffer, and analyzed by PCR and agarose gel electrophoresis. The primer pairs used are listed in Table 1 .
Statistic analysis
Quantitative data are presented as the mean (±SE), and were analyzed by analysis of variance and Duncan's multiple-range test at a significance level of 0.05 using the general linear model of the SAS program (SAS Institute Inc., Cary, NC). Differences between two treatment groups were analyzed using the Student's t-test at a significance level of 0.05.
RESULTS
Pituitary gonadotropin FSH acting together with cytokine TGFβ1 facilitates ovarian granulosa cell differentiation marked by an enhancement of progesterone synthesis (24) (25) (26) (27) 29 ). We are interested to understand how FSH and TGFβ1 regulate cholesterol availability for active steroidogenesis, and how the machinery of cellular cholesterol homeostatic control works in ovarian granulosa cells.
FSH and TGFβ1 regulation of SR-BI and LDLR in steroidogenic granulosa cells
We first investigated the temporal profile of FSH and TGFβ1 regulation of SR-BI and LDLR expression in rat ovarian granulosa cells. Immunoblotting analysis showed that at 6-and 12-h post-treatment, FSH±TGFβ1 similarly increased SR-BI and LDLR protein levels with a greater effect on SR-BI ( Figure 1A ). While TGFβ1 treatment alone had no effect (data not shown), it augmented FSH action and retained high levels of SR-BI and LDLR at 24-and 48-h post-treatment ( Figure 1A) . Interestingly, granulosa cells treated with FSH for 48 h still had SR-BI protein level significantly higher than the control, whereas LDLR level was lower than the control ( Figure 1A ). Next, we employed immunofluorescence analysis to observe subcellular localization of SR-BI and LDLR. After 24 h of treatment, control and TGFβ1-treated cells showed weak immunostaining activity of SR-BI present at the nucleus and cytoplasm, and FSH treatment increased such staining activity in both compartments 
Potential functional role of SR-BI and LDLR in steroidogenic granulosa cells
The cholesterol uptake activity of SR-BI and LDLR in ovarian granulosa cells was investigated by examining FSH and TGFβ1 stimulation of progesterone production under hHDL 3 or hLDL supplementation with the combined use of BLT-1 (experimental designs shown in Figures 2A and 3A) . BLT-1 is a small molecule inhibitor that blocks the selective CE uptake activity of SR-BI (35, 36). hHDL 3 is rich in apoA-I and devoid of apoB and apoE, and was reported to have a high affinity for SR-BI but not LDLR (5, 37) . hLDL, on the other hand, is a ligand for LDLR and SR-BI (5), and thus cells could obtain hLDL-derived cholesterol from both pathways. These results together suggest that in ovarian granulosa cells, FSH and TGFβ1-upregulated SR-BI is functional for hHDL 3 -cholesterol uptake, and hLDL-cholesterol could be internalized through both LDLR and SR-BI pathways; furthermore, cholesterol from both routes could be used for steroid hormone synthesis and stored in lipid droplets.
Differential sterol responsiveness of SR-BI and LDLR in steroidogenic granulosa cells
We further explored how lipoprotein supplementation modulates the expression of These results together clearly demonstrate that Ldlr and Hmgcr, and Scarb1 genes display differential response to sterol challenge in steroidogenic granulosa cells, and that SREBP may be involved in the process.
Potential role of SREBP and LRH-1 in differential sterol responsiveness of SR-BI and LDLR in steroidogenic granulosa cells
To further identify the underlying mechanisms for differential sterol effect on Ldlr and Scarb1 in ovarian granulosa cells, we focused on two key transcription factors, SREBP-2 and LRH-1. SREBP-2 is the SREBP isoform that preferentially regulates cholesterogenic genes, including Ldlr (38). Also, a previous study reported that Scarb1 promoter contains a proximal sterol response element (SRE) and a nuclear receptor NR5A response element (NRE) (18) . Additionally, LRH-1 has been known to transactivate Scarb1 (40), and is specifically expressed in the granulosa cell layer in ovary (41). (Figures 2 to 4) . hHDL 3 was reported to have a high affinity for SR-BI but not LDLR, while hLDL is a ligand for LDLR and SR-BI (5, 37). Treatment with BLT-1 (a selective inhibitor of SR-BI) almost completely blocked the hHDL 3 supplementation-enhanced FSH+TGFβ1-stimulated progesterone production, but only partially reduced the effect of hLDL (Figures 2 and 3) , suggesting that hHDL 3 is largely uptaken through SR-BI, whereas hLDL could be uptaken through both LDLR and SR-BI to enhance progesterone synthesis. Moreover, we found that lipoprotein-derived cholesterol accumulation (reflected by BODIPY 493/503-stained neutral lipids) was apparent and by guest, on November 9, 2017 www.jlr.org Downloaded from related to the receptor level, and this phenomenon was enhanced when steroidogenic process was blocked by P450scc inhibitor AMG (Figure 4) . In cells given hHDL 3 ±AMG the staining intensity was related to SR-BI level at 48-h post-treatment (control < FSH < FSH+TGFβ1; Figures 1A and 4) . In cells given hLDL±AMG, the staining intensity was related to cellular level of LDLR (FSH < control < FSH+TGFβ1; Figures 1A and 4) .
Interestingly, we also noticed that at 24-h post-treatment, FSH-treated cells had LDLR protein level similar to the control group while having SR-BI level greater than the control, yet hLDL supplementation-enhanced progesterone production was not affected by BLT-1 pretreatment ( Figures 1A and 3) . Though both receptors were reported capable of uptaking cholesterol from LDL (5), our study suggests that hLDL-cholesterol may be more efficiently uptaken through LDLR than SR-BI.
In non-steroidogenic cells, cellular cholesterol has been clearly demonstrated to be under negative feedback regulation involving transcription factors SREBPs with Ldlr and
Hmgcr being two canonical SREBP targets (17) ; whether SREBP regulates SR-BI is unclear.
This study identifies that in steroidogenic granulosa cells, LDLR is also subjected to cholesterol homeostatic control mechanism similar to non-steroidogenic cells; interestingly, SR-BI responds to sterol challenge differently from LDLR. This is supported by the following lines of evidence. First, supplying granulosa cells lipoproteins downregulated the FSH and TGF1-increased expression of Ldlr and Hmgcr but not Scarb1 (Figures 5 and 6) . Importantly, we identified LRH-1 as a crucial transcription factor that mediates SR-BI response to sterol challenge, and LRH-1 is regulated by FSH and TGF1. FSH increased LRH-1 protein level, and TGF1 potentiated FSH action ( Figure 8B ). Additionally, FSH plus TGF1 increased LRH-1 binding to Scarb1 promoter region containing a putative NRE site, while no significant binding was detected on Ldlr ( Figure 8D ). Moreover, 25-OHC in the absence or presence of AMG reduced the FSH plus TGF1-increased LRH-1 at 24-h post-treatment, and this is parallel to the change of SR-BI; whereas no effect was detected at 
